BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12534032)

  • 1. [Prognostic evaluation of histological criteria in central nervous system astrocytomas: 51 cases].
    Trabelsi S; Haouet S; Mekni A; Bouraoui S; Bellil K; Kchir N; Zitouna MM
    Tunis Med; 2002 May; 80(5):274-7. PubMed ID: 12534032
    [No Abstract]   [Full Text] [Related]  

  • 2. Grading astrocytomas.
    Adelman LS
    Neurosurg Clin N Am; 1994 Jan; 5(1):35-41. PubMed ID: 8124092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytic gliomas: characterization on a molecular genetic basis.
    von Deimling A; Louis DN; Schramm J; Wiestler OD
    Recent Results Cancer Res; 1994; 135():33-42. PubMed ID: 8047695
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspects on the survival of patients with glioblastoma and the origin and histology of oligodendrogliomas.
    Linz U
    Nat Rev Cancer; 2003 Jul; 3(7):doi:10.1038/nrc1121-c1. PubMed ID: 19006840
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.
    Combs SE; Thilmann C; Edler L; Debus J; Schulz-Ertner D
    J Clin Oncol; 2005 Dec; 23(34):8863-9. PubMed ID: 16314646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral astrocytic neoplasms in the adult: contribution of histologic examination to the assessment of prognosis.
    Fulling KH; Nelson JS
    Semin Diagn Pathol; 1984 May; 1(2):152-63. PubMed ID: 6100972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.
    Kirla RM; Haapasalo HK; Kalimo H; Salminen EK
    Cancer; 2003 Feb; 97(3):644-8. PubMed ID: 12548606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Items (tumors) worthy of special mention in the proposed new WHO histological classification of tumors of the central nervous system].
    Ishida Y
    No To Shinkei; 1994 Dec; 46(12):1127-32. PubMed ID: 7893529
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognostic implications of the proliferation index (H3-TdR-labeling index) and ploidy in neuroectodermal tumors (astrocytomas and glioblastomas)].
    Lavezzi AM; Biondo B; Repetti ML; Varesi C; Masini B; Matturri L
    Minerva Med; 1992 Mar; 83(3):115-9. PubMed ID: 1313162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary tumors of the central nervous system: histogenetic classification, grade of malignity, clinico-pathologic features, and therapeutic criteria].
    Bisceglia M; D'Angelo V; Parisi S; Lelli G; Pasquinelli G; Cenacchi G; Giangaspero F
    Pathologica; 2000 Dec; 92(6):534-61. PubMed ID: 11234305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord malignant astrocytomas. Clinicopathologic features in 36 cases.
    Santi M; Mena H; Wong K; Koeller K; Olsen C; Rushing EJ
    Cancer; 2003 Aug; 98(3):554-61. PubMed ID: 12879473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrepresentative astrocytoma biopsy sampling is partly overcome by assessment of the MIB-1-labelled growth fraction.
    Sheehan KM; Kay EW; Burke M; Heffernan J; Brett FM; Farrell MA
    J Clin Pathol; 2007 Aug; 60(8):945-7. PubMed ID: 17412876
    [No Abstract]   [Full Text] [Related]  

  • 13. Histological correlations with survival in malignant gliomas.
    Safdari H; Hochberg FH; Richardson EP
    Acta Neurochir Suppl (Wien); 1979; 28(2):485-8. PubMed ID: 225937
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytology of tumors of the central nervous system.
    Piaton E
    Acta Cytol; 1996; 40(4):846-8. PubMed ID: 8693914
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
    Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M; Molenaar W; Go GK
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Classification of the astrocytic gliomas. Brief comments].
    Pérez-Ortiz L; Galarraga J; Gómez-Suárez H; Tamayo-Suárez JD
    Rev Neurol; 2000 Dec 16-31; 31(12):1180-3. PubMed ID: 11205555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation and programmed cell death: role of p53 protein in high and low grade astrocytoma.
    Facoetti A; Ranza E; Nano R
    Anticancer Res; 2008; 28(1A):15-9. PubMed ID: 18383819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pilomyxoid astrocytoma. Three cases and review].
    Domínguez-Páez M; Weil-Lara B; Rodríguez-Barceló S; Medina-Imbroda JM; Puch-Ramírez M; Ros-López B; Arráez-Sánchez MA
    Neurocirugia (Astur); 2010 Feb; 21(1):22-9. PubMed ID: 20186371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-operative characterization of gliomas by near-infrared spectroscopy: possible association with prognosis.
    Asgari S; Röhrborn HJ; Engelhorn T; Stolke D
    Acta Neurochir (Wien); 2003 Jun; 145(6):453-59; discussion 459-60. PubMed ID: 12836069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.